Data di Pubblicazione:
2005
Abstract:
To define the role of surgical management of lung metastases in ACC. Twenty ACC patients referred to lung metastasectomy were retrospectively reviewed. Twenty-six operations were performed; at the first metastasectomy, a resection with clear margins (R0) was achieved in 11 patients (55%), 3 are alive and well. Four out of 9 patients with residual disease (R2) are still alive. Median survival after metastasectomy was 78 and 52 months for R0 and R2 (p = 0.4); median freedom from progression (FFP) in R0 and R2 groups was 30 and 15 months (p = 0.2), respectively. A better outcome was obtained for patients with a disease-free interval ≥36 months and ≥6 metastases and bilateral involvement were critical in achieving a R0 intervention. Lung metastasectomy provided a prolonged FFP in a high selected subset of patients with ACC. However, if this could be translated into a survival benefit, it is still to be demonstrated. © 2005 Elsevier Ltd. All rights reserved.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adenoid cystic carcinoma; Head and neck cancer; Lung metastases; Metastasectomy; Salivary gland carcinoma
Elenco autori:
Locati, L. D.; Guzzo, M.; Bossi, P.; Massone, P. P. B.; Conti, B.; Fumagalli, E.; Bareggi, C.; Cantu, G.; Licitra, L.
Link alla scheda completa:
Pubblicato in: